Lisinopril/HCTZ
- Product NDC
- 61919-523
- 11-digit product format
- 619190523
- Labeler code
- 61919
- Product ID
- 61919-523_ea4e7175-945f-6be8-e053-2a95a90a507c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril/HCTZ
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2019-08-07
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-523-30 | Lisinopril/HCTZ | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 61919-523-90 | Lisinopril/HCTZ | 90 in 1 BOTTLE | TABLET | 90 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-523 | LISINOPRIL TABLET LISINOPRIL/HCTZ TABLET [DIRECT_RX] | 2 | Legacy NDC, 1 package rows | 20190418_80221abf-6e01-c8c2-e053-2a91aa0a82b8.zip |
| 61919-523 | LISINOPRIL/HCTZ TABLET [DIRECT_RX] | 2 | Legacy NDC, 1 package rows | 20221007_8f8cfb63-073c-c156-e053-2995a90a61e7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-523-30 | 61919052330 | 30 TABLET in 1 BOTTLE (61919-523-30) | 30 tablet | 2019-08-07 | 0000-00-00 | No | No | Current |
| 61919-523-90 | 61919052390 | 90 TABLET in 1 BOTTLE (61919-523-90) | 90 tablet | 2019-04-18 | 0000-00-00 | No | No | Current |